DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4,024 | -99.9% | 13,718 | -1.2% | 0.65% | -11.6% |
Q3 2022 | $3,587,000 | +4.2% | 13,886 | +2.2% | 0.73% | +12.4% |
Q2 2022 | $3,444,000 | -14.4% | 13,586 | -1.0% | 0.65% | +0.6% |
Q1 2022 | $4,024,000 | -9.8% | 13,718 | +1.2% | 0.65% | -9.3% |
Q4 2021 | $4,462,000 | +9.8% | 13,561 | +1.6% | 0.71% | -0.3% |
Q3 2021 | $4,065,000 | +10.6% | 13,354 | -2.5% | 0.72% | +11.7% |
Q2 2021 | $3,674,000 | +19.4% | 13,690 | +0.2% | 0.64% | +9.2% |
Q1 2021 | $3,076,000 | +4.0% | 13,665 | +2.6% | 0.59% | -6.5% |
Q4 2020 | $2,959,000 | +4.2% | 13,319 | +1.0% | 0.63% | -7.9% |
Q3 2020 | $2,839,000 | +21.1% | 13,186 | -0.5% | 0.68% | +8.8% |
Q2 2020 | $2,344,000 | +37.8% | 13,255 | +7.8% | 0.63% | +6.6% |
Q1 2020 | $1,701,000 | -24.9% | 12,292 | -16.7% | 0.59% | +0.5% |
Q4 2019 | $2,264,000 | +15.7% | 14,754 | +8.9% | 0.58% | +3.4% |
Q3 2019 | $1,956,000 | -5.1% | 13,543 | -6.1% | 0.56% | -6.3% |
Q2 2019 | $2,062,000 | +5.9% | 14,427 | -2.2% | 0.60% | +3.4% |
Q1 2019 | $1,947,000 | +31.6% | 14,745 | +2.8% | 0.58% | +13.0% |
Q4 2018 | $1,479,000 | -3.1% | 14,344 | +2.1% | 0.52% | +6.4% |
Q3 2018 | $1,526,000 | +22.4% | 14,049 | +11.1% | 0.48% | +18.6% |
Q2 2018 | $1,247,000 | – | 12,641 | – | 0.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |